Get started
Author

Matthias Sandmann

Observed names: M Sandmann, M. Sandmann
ORCID: 0009-0008-8785-9999
Observed ORCID: 0009-0008-8785-9999
OpenAlex ID: A5011049804
Treatment of the bone marrow failure in Fanconi anemia patients with danazol
2011 · Kathrin Scheckenbach, Mary Morgan, et al. · Blood Cells Molecules and Diseases · 63
Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
2020 · Christine Schmitz, Jan Rekowski, et al. · Hematological Oncology · 28
PDF
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
2025 · Sebastian Stintzing, Susanne Klein-Scory, et al. · Journal of Clinical Oncology · 22
FIRE-4 (AIO KRK-0114): Randomized study evaluating the efficacy of cetuximab re-challenge in patients with metastatic RAS wild-type colorectal cancer responding to first-line treatment with FOLFIRI plus cetuximab.
2025 · Lena Weiss, Volker Heinemann, et al. · Journal of Clinical Oncology · 14
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial
2016 · Andreas Hüttmann, Stefan P Müller, et al. · Blood · 9
Randomized study to investigate a switch maintenance concept with 5-FU plus bevacizumab after FOLFIRI plus cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab: Report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114).
2022 · Sebastian Stintzing, Ludwig von Weikersthal, et al. · Journal of Clinical Oncology · 8
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
2024 · Ulrich Dührsen, Andreas Bockisch, et al. · Blood Neoplasia · 5
Phase III FIRE-4 study (AIO KRK-0114): Evaluation of first-line treatment efficacy of FOLFIRI/cetuximab in patients with RAS-WT mCRC receiving the first cycle of treatment with chemotherapy only.
2023 · Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al. · Journal of Clinical Oncology · 4
PDF
Akute generalisierte Katzenkratzkrankheit bei myelodysplastischem Syndrom
2001 · J. Baier, P. Altmeyer, et al. · Der Hautarzt · 2
Safety of Front-Line R-Mini-CHOP with or without Acalabrutinib in Older Adults with DLBCL - an Interim Analysis of Serious Adverse Events in the Arched / GLA 2022-1 Randomized, Open-Label, Phase 3 Trial
2024 · Konstantinos Christofyllakis, Igor Age Kos, et al. · Blood · 1
FIRE-4 (AIO KRK-0114): Efficacy of third-line rechallenge with cetuximab versus investigator’s choice in relation to the interval between initial and third-line anti-EGFR therapy.
2026 · Lena Weiss, Sebastian Stintzing, et al. · Journal of Clinical Oncology
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial
2025 · Ulrich Dührsen, Gabriele Prange-Krex, et al. · Annals of Hematology
PDF
SO-16 FIRE-4 (AIO-KRK-0114): Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab – secondary endpoint
2022 · V. Heinemann, L. Fischer von Weikersthal, et al. · Annals of Oncology
PDF
Lymphozytäre Alveolitis mit erhöhtem CD4-/CD8-Quotienten – Diagnosen jenseits der Sarkoidose
2017 · S Stieglitz, M Welsner, et al. · Pneumologie
Sarkoidose-Lymphom-Syndrom
2016 · S Stieglitz, J Kempchen, et al. · Pneumologie
Fallserie zur Endoskopischen Vollwandresektion anhand zweier unterschiedlicher Techniken (Dortmunder Methode und FTRD-System) mithilfe des OTSC-Systems
2015 · M Fähndrich, M Sandmann · Zeitschrift für Gastroenterologie
Erfolgreicher primärer Perforationsverschluss nach Papillotomie mithilfe des OTSC®-Systems mit anschließender Entfernung des Vollwand-Clips mit dem Nd:YAG-Laser
2010 · M Fähndrich, M Sandmann, et al. · Zeitschrift für Gastroenterologie
Erfolgreiche Entfernung des OTSC®-Systems durch Destruktion mittels Nd:YAG-Laser
2010 · M Fähndrich, M Sandmann, et al. · Zeitschrift für Gastroenterologie
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin’s lymphoma
2008 · P. Schütt, K. Zimmermann, et al. · Journal of Cancer Research and Clinical Oncology
Koloskopische Lavage mit intraluminaler Vancomycin-Applikation als effektive Behandlung schwerster Verläufe der pseudomembranösen Kolitis. Kasuistik von 2 Fällen mit Ileus und 2 Fällen mit fulminanter Colitis
2006 · KJ Goerg, C Beier, et al. · Zeitschrift für Gastroenterologie
Works count: 20
Citation count: 156
H-index: 6
I10-index: 4
Year
Topic
Type